| RE50497 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds +5 more |
2025-07-22 |
| RE49445 |
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds +5 more |
2023-03-07 |
| RE48285 |
N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds +5 more |
2020-10-27 |
| 10245268 |
Treatment of ACVR1-mediated diseases |
Brian Koh, Igor THEURL, Matthew Robert Warr |
2019-04-02 |
| 9809559 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds +5 more |
2017-11-07 |
| 9469613 |
(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide |
Brandon Heath Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds +5 more |
2016-10-18 |